Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history

doi:10.3748/wjg.v25.i37.5676

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10011)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

699

WORD

148

HTML

5812

Figures (1-2)

267

Tables (1-4)

209

Sum=7135

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1001

Download

1875

Sum=2876

Oct 7, 2019 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (50)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Oct 7, 2019; 25(37): 5676-5686
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5676

Open in New Tab Full Size Figure Download Figure

Figure 1 Study flow chart. IBD: Inflammatory bowel disease; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease.

Open in New Tab Full Size Figure Download Figure

Figure 2 Nonalcoholic fatty liver disease patients showed a significantly longer disease remission compared to inflammatory bowel disease patients without nonalcoholic fatty liver disease. 33.9 mo vs 21.14, P < 0.05.

Citation: Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World J Gastroenterol 2019; 25(37): 5676-5686
URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5676.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5676